![[MigVax in i24NEWS] Israeli Covid vaccine tablet receives $4.3 million in funding](https://blog.ourcrowd.com/wp-content/uploads/2017/11/i24-news-NEW.jpg)
MigVax is one of two recipients for Coalition for Epidemic Preparedness Innovations funding awards A coalition funded by Bill Gates dedicated to fighting Covid awarded $4.3 million to an Israeli company for development of a variant-proof vaccine that comes in tablet form. Read...
Read More![[MigVax in NoCamels] Israel’s MigVax receives $4.3M award for development of oral vaccine](https://blog.ourcrowd.com/wp-content/uploads/2017/10/nocamels-NEW.jpg)
Israel’s MigVax, the affiliate company established by Israeli scientists at the Migal Galilee Research Institute to develop a vaccine for the coronavirus, has received a $4.3 million award from Norway’s Coalition of Epidemic Preparedness Innovations (CEPI) to help support the initial development of its COVID-19 oral subunit vaccine tablet. Read...
Read More![[MigVax in Hamodia] Gates Foundation awards $4.3m for development of Covid pill](https://blog.ourcrowd.com/wp-content/uploads/2021/11/hamodia-web.png)
Millions of pounds are being ploughed into developing variant-proof Covid vaccines that could be as effective against future strains as those circulating now. Scientists fear that current jabs could offer little protection against new versions of the Sars-Cov-2 virus – putting the world back to square one. The international Coalition for Epidemic Preparedness Innovations, to which the UK has contributed £260 million, is backing two projects. Israeli firm MigVax has been given £3.2 million to advance a vaccine pill known as MigVax-101, which would work as an easy-to-administer booster, and the University of Saskatchewan in Canada has been given £3.7 million to develop its own version. Read...
Read More![[MigVax in Daily Mail] Cash injection for scientists developing variant-proof Covid vaccines](https://blog.ourcrowd.com/wp-content/uploads/2021/11/dailymail-uk.png)
Millions of pounds are being ploughed into developing variant-proof Covid vaccines that could be as effective against future strains as those circulating now. Scientists fear that current jabs could offer little protection against new versions of the Sars-Cov-2 virus – putting the world back to square one. The international Coalition for Epidemic Preparedness Innovations, to which the UK has contributed £260 million, is backing two projects. Israeli firm MigVax has been given £3.2 million to advance a vaccine pill known as MigVax-101, which would work as an easy-to-administer booster, and the University of Saskatchewan in Canada has been given £3.7 million to develop its own version. Read...
Read More![[MigVax in The Times Of Israel] Israeli plan for COVID vaccine tablet gets $4.3m from Bill Gates-backed fund](https://blog.ourcrowd.com/wp-content/uploads/2017/10/the-times-of-israel-NEW.jpg)
A COVID-fighting coalition heavily funded by Bill Gates has awarded $4.3 million for development of an Israeli variant-proof vaccine in tablet form. The Bill and Melinda Gates Foundation is a founder of the Oslo-based Coalition for Epidemic Preparedness Innovations, and last October committed $20 million to it. CEPI now has a $200 million program to advance vaccine development, and has just announced its first funding awards. MigVax, a poultry vaccine that is being adapted for humans in the Galilee, is one of the two recipients. Read...
Read More
